Dr. Woyach on BTK Inhibition and the Mechanism of Action of Ibrutinib Targeted Oncology 1:17 11 years ago 2 273 Далее Скачать
Progress With BTK Inhibitors: A Journey Through the Mechanisms of Covalent and Noncovalent Options PeerView Oncology 22:36 2 years ago 2 246 Далее Скачать
BTK inhibitors: Investigating disease relevant mechanisms in multiple sclerosis VJNeurology 3:51 2 years ago 480 Далее Скачать
What are BTK Inhibitors and Why Are They Different? From the Spring 2023 Education Summit TheMSCenter 22:57 1 year ago 2 124 Далее Скачать
Selecting BTK inhibitors for patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 1 year ago 192 Далее Скачать
Updated results of Phase I/II BRUIN study: pirtobrutinib in covalent BTK inhibitor pretreated MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:56 1 year ago 117 Далее Скачать
BTK and Immune Diseases | MOD Animation XVIVO Scientific Animation 2:11 2 years ago 5 736 Далее Скачать
Dr. Shah on Overcoming Resistance to BTK Inhibitors in MCL OncLive 1:10 5 years ago 193 Далее Скачать
Efficacy of pirtobrutinib in patients with R/R MCL previously treated with a covalent BTKi VJHemOnc – Video Journal of Hematology & HemOnc 2:23 1 year ago 135 Далее Скачать
BTK inhibitors for R/R MCL: current uses and insights from the ViPOR study VJHemOnc – Video Journal of Hematology & HemOnc 2:40 1 year ago 152 Далее Скачать